Evidence map›Paper›PMID 32517739›Full record

Trial reportBMC musculoskeletal disorders2020

Cooled radiofrequency ablation provides extended clinical utility in the management of knee osteoarthritis: 12-month results from a prospective, multi-center, randomized, cross-over trial comparing cooled radiofrequency ablation to a single hyaluronic acid injection.

Antonia F Chen, Fred Khalouf, Keith Zora, Michael DePalma, Lynn Kohan, Maged Guirguis, Douglas Beall, Eric Loudermilk, Matthew J Pingree, Ignacio Badiola and 1 more

2 registry-linked trialsOpen access · goldAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC musculoskeletal disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03381248 nacompletednot on this map

A Prospective, Multi-center, Randomized, Clinical Trial Evaluating the Safety and Effectiveness of Using COOLIEF™ Cooled Radiofrequency Probe to Create Lesions of the Genicular Nerves and Comparing a Single Injection of Hyaluronic Acid in the Management of Knee Pain

TypeinterventionalSponsorAvanos MedicalRan2017 to 2020Enrolled177ConditionsOsteoarthritis of the KneeArmsCooled Radiofrequency, Hyaluronic Acid Injection, Crossover from Hyaluronic Acid Injection to Cooled Radiofrequency
NCT05700253 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Comparing Pain Outcomes of Cooled Radiofrequency Ablation and Hyaluronic Acid Therapies for Chronic Osteoarthritis Knee Patients

TypeinterventionalSponsorChangi General HospitalRan2023 to 2024Enrolled76ConditionsOsteoarthritis, Knee, PainArmsCooled Radiofrequency Ablation, Hyaluronic Acid Injection
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Knee osteoarthritis: disease burden, available treatments, and emerging options.Therapeutic advances in musculoskeletal disease · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Antonia F ChenDepartment of Orthopaedics, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA. afchen@bwh.harvard.edu.ORCID http://orcid.org/0000-0003-2040-8188
Fred KhaloufUniversity Orthopedics Center, 3000 Fairway Dr, Altoona, PA, 16602, USA.
Keith ZoraUniversity Orthopedics Center, 476 Rolling Ridge Drive, State College, PA, 16801, USA.
Michael DePalmaVirginia iSpine Physicians, 9020 Stony Point Pkwy #140, Richmond, VA, 23235, USA.
Lynn KohanUniversity of Virginia School of Medicine, 545 Ray C Hunt Drive, Charlottesville, VA, 22903, USA.
Maged GuirguisOchsner Clinic Foundation, 2820 Napoleon Ave, Ste 210A, New Orleans, LA, 70115, USA.
Douglas BeallClinical Investigations, 1800 Renaissance Blvd Suite 110, Edmond, OK, 73013, USA.
Eric LoudermilkPCPMG Clinical Research Unit LLC, 100 Healthy Way #1260, Anderson, SC, 29621, USA.
Matthew J PingreeMayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Ignacio BadiolaUniversity of Pennsylvania, 3737 Market Street Room 6113, Philadelphia, PA, 19104, USA.
Jeffrey LymanInstitute for Orthopedic Research and Innovation, 1110 W Park Place, Suite 212, Coeur d'Alene, ID, 83814, USA.
University Orthopedics Center · USBrigham and Women's Hospital · USMayo Clinic · USNorth Idaho College · USOchsner Medical Center · USUniversity of Pennsylvania · USUniversity of Virginia · USVirginia Spine Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSafe and effective non-surgical treatments are an important part of the knee osteoarthritis (OA) treatment algorithm. Cooled radiofrequency ablation (CRFA) and hyaluronic acid (HA) injections are two commonly used modalities to manage symptoms associated with knee OA.

methodsA prospective 1:1 randomized study was conducted in 177 patients comparing CRFA to HA injection with follow-ups at 1, 3, 6 and 12 months. HA subjects with unsatisfactory outcomes at 6-months were allowed to crossover and receive CRFA. Knee pain (numeric rating scale = NRS), WOMAC Index (pain, stiffness and physical function), overall quality of life (global perceived effect = GPE, EQ-5D-5 L), and adverse events were measured.

resultsAt 12-months, 65.2% of subjects in the CRFA cohort reported ≥50% pain relief from baseline. Mean NRS pain score was 2.8 ± 2.4 at 12 months (baseline 6.9 ± 0.8). Subjects in the CRFA cohort saw a 46.2% improvement in total WOMAC score at the 12-month timepoint. 64.5% of subjects in the crossover cohort reported ≥50% pain relief from baseline, with a mean NRS pain score of 3.0 ± 2.4 at 12 months (baseline 7.0 ± 1.0). After receiving CRFA, subjects in the crossover cohort had a 27.5% improvement in total WOMAC score. All subjects receiving CRFA reported significant improvement in quality of life. There were no serious adverse events related to either procedure and overall adverse event profiles were similar.

conclusionA majority of subjects treated with CRFA demonstrated sustained knee pain relief for at least 12-months. Additionally, CRFA provided significant pain relief for HA subjects who crossed over 6 months after treatment.

trial registrationThis trial was registered on ClinicalTrials.gov, NCT03381248. Registered 27 December 2017.

Indexed as

AdultAgedAged, 80 and overCross-Over StudiesFemaleHumansHyaluronic AcidInjections, Intra-ArticularKnee JointMaleMiddle AgedOsteoarthritis, KneePain MeasurementProspective StudiesQuality of LifeRadiofrequency AblationHyaluronic AcidDenervationNon-surgicalOsteoarthritisRadiofrequency ablation

Identifiers

PMID32517739
PMCPMC7285532
OpenAlexW3033358266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.